Biblio Discovery — Demo Discovery Service

10 hasil untuk "Nancy U. Lin"

Menampilkan 1–10 · 0,41 detik · RSS

  1. Artikel Jurnal

    Global challenges and policy solutions in breast cancer control

    Dario Trapani; Ophira Ginsburg; Temidayo A. Fadelu dkk.

    Cancer Treatment Reviews · 2022 · Inggris · OpenAlex Scopus

    Breast cancer is the leading cause of cancer morbidity, disability and mortality in women, worldwide. Overall, in 2020, it was the most diagnosed malignancy. Differences in breast cancer mortality have been historically evidenced, as a result of disparities in access to diagnosis, treatment and…

  2. Artikel Jurnal Teks lengkap

    STING agonism reprograms tumor-associated macrophages and overcomes resistance to PARP inhibition in BRCA1-deficient models of breast cancer

    Qiwei Wang; Johann S. Bergholz; Liya Ding dkk.

    Nature Communications · 2022 · Inggris · OpenAlex Scopus

    Abstract PARP inhibitors (PARPi) have drastically changed the treatment landscape of advanced ovarian tumors withBRCAmutations. However, the impact of this class of inhibitors in patients with advancedBRCA-mutant breast cancer is relatively modest. Using a syngeneic genetically-engineered mouse…

  3. Artikel Jurnal Teks lengkap

    Consensus recommendations for a standardized brain tumor imaging protocol for clinical trials in brain metastases

    Timothy J. Kaufmann; Marion Smits; Jerrold L. Boxerman dkk.

    Neuro-Oncology · 2020 · Inggris · OpenAlex Scopus

    A recent meeting was held on March 22, 2019, among the FDA, clinical scientists, pharmaceutical and biotech companies, clinical trials cooperative groups, and patient advocacy groups to discuss challenges and potential solutions for increasing development of therapeutics for central nervous system…

  4. Artikel Jurnal Teks lengkap

    Intracranial Efficacy and Survival With Tucatinib Plus Trastuzumab and Capecitabine for Previously Treated HER2-Positive Breast Cancer With Brain Metastases in the HER2CLIMB Trial

    Nancy U. Lin; Virginia F. Borges; Carey K. Anders dkk.

    Journal of Clinical Oncology · 2020 · Inggris · OpenAlex Scopus

    PURPOSE In the HER2CLIMB study, patients with human epidermal growth factor receptor 2 (HER2)–positive breast cancer with brain metastases (BMs) showed statistically significant improvement in progression-free survival (PFS) with tucatinib. We describe exploratory analyses of intracranial efficacy…

  5. Artikel Jurnal

    The Genomic Landscape of Intrinsic and Acquired Resistance to Cyclin-Dependent Kinase 4/6 Inhibitors in Patients with Hormone Receptor–Positive Metastatic Breast Cancer

    Seth Andrew Wander; Ofir Cohen; Xueqian Gong dkk.

    Cancer Discovery · 2020 · Inggris · OpenAlex Scopus

    Abstract Mechanisms driving resistance to cyclin-dependent kinase 4/6 inhibitors (CDK4/6i) in hormone receptor–positive (HR+) breast cancer have not been clearly defined. Whole-exome sequencing of 59 tumors with CDK4/6i exposure revealed multiple candidate resistance mechanisms including RB1 loss…

  6. Artikel Jurnal Teks lengkap

    21-Gene Assay to Inform Chemotherapy Benefit in Node-Positive Breast Cancer

    Kevin Kalinsky; William E. Barlow; Julie R. Gralow dkk.

    New England Journal of Medicine · 2021 · Inggris · OpenAlex Scopus

    BACKGROUND: The recurrence score based on the 21-gene breast-cancer assay has been clinically useful in predicting a chemotherapy benefit in hormone-receptor-positive, human epidermal growth factor receptor 2 (HER2)-negative, axillary lymph-node-negative breast cancer. In women with positive…

  7. Artikel Jurnal

    Survival in Patients With Brain Metastases: Summary Report on the Updated Diagnosis-Specific Graded Prognostic Assessment and Definition of the Eligibility Quotient

    Paul W. Sperduto; Shane M. Mesko; Jing Li dkk.

    Journal of Clinical Oncology · 2020 · Inggris · OpenAlex Scopus

    PURPOSE: Conventional wisdom has rendered patients with brain metastases ineligible for clinical trials for fear that poor survival could mask the benefit of otherwise promising treatments. Our group previously published the diagnosis-specific Graded Prognostic Assessment (GPA). Updates with larger…

  8. Artikel Jurnal

    HER2-Mediated Internalization of Cytotoxic Agents in ERBB2 Amplified or Mutant Lung Cancers

    Bob T. Li; Flavia Michelini; Sandra Misale dkk.

    Cancer Discovery · 2020 · Inggris · OpenAlex Scopus

    Abstract Amplification of and oncogenic mutations in ERBB2, the gene encoding the HER2 receptor tyrosine kinase, promote receptor hyperactivation and tumor growth. Here we demonstrate that HER2 ubiquitination and internalization, rather than its overexpression, are key mechanisms underlying…